Transcatheter Aortic Valve Replacement Failure

Circulation: Cardiovascular Interventions

Volumn 8, Issue 4, 2015, Pages

  Mylotte, Darren ^a   Piazza, Nicolo ^b,c  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Editorials; transcatheter aortic valve replacement

Indexed keywords

ANTICOAGULANT THERAPY; AORTA STENOSIS; AORTA VALVE PROSTHESIS; HUMAN; PRIORITY JOURNAL; PROSTHETIC VALVE DYSFUNCTION; PROSTHETIC VALVE ENDOCARDITIS; PROSTHETIC VALVE THROMBOSIS; REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; ENDOCARDITIS, NON-INFECTIVE; FEMALE; HEART VALVE PROSTHESIS; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RADIOGRAPHY; THROMBOSIS;

AORTIC VALVE; AORTIC VALVE STENOSIS; ENDOCARDITIS, NON-INFECTIVE; FEMALE; HEART VALVE PROSTHESIS; HUMANS; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84936097867     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.002531     Document Type: Review

References (24)

1. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607. Doi: 10. 1056/NEJMoa1008232.
2. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M, Chenoweth S, Oh JK; U. S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-1798. Doi: 10. 1056/NEJMoa1400590.
3. Mylotte D, Andalib A, Theriault-Lauzier P, Dorfmeister M, Girgis M, Alharbi W, Chetrit M, Galatas C, Mamane S, Sebag I, Buithieu J, Bilodeau L, de Varennes B, Lachapelle K, Lange R, Martucci G, Virmani R and Piazza N. Transcatheter heart valve failure: a systematic review [published online ahead of print September 28, 2014]. Eur Heart J. Pii: ehu388.
4. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Davidson MJ, Svensson LG and Akin J. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial [published online ahead of print March 15, 2015]. Lancet. Doi: 10. 1016/ S0140-6736(15)60308-7.
5. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, Webb JG, Mack MJ, Douglas PS, Thourani VH, Babaliaros VC, Herrmann HC, Szeto WY, Pichard AD, Williams MR, Fontana GP, Miller DC, Anderson WN, Smith CR, Akin JJ, Davidson MJ. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial [published online ahead of print March 15, 2015]. Lancet. Doi: 10. 1016/S0140-6736(15)60290-2.
6. International Symposium on Surgery for Heart Valve Disease London. Surgery for Heart Valve Disease: Proceedings of the 1989 Symposium. London: ICR Publishers; 1990.
7. Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR, Danielson GK, Orszulak TA, Pluth JR, Puga FJ, Schaff HV, Larsonkeller JJ. High risk of thromboemboli early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol. 1995;25:1111-1119.
8. Vesey JM, Otto CM. Complications of prosthetic heart valves. Curr Cardiol Rep. 2004;6:106-111.
9. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84-e231.
10. Pibarot P, Dumesnil JG. Prosthetic heart valves: selection of the optimal prosthesis and long-term management. Circulation. 2009;119:1034-1048. Doi: 10. 1161/CIRCULATIONAHA. 108. 778886.
11. Trepels T, Martens S, Doss M, Fichtlscherer S, Schächinger V. Images in cardiovascular medicine. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. Circulation. 2009;120:e23-e24. Doi: 10. 1161/CIRCULATIONAHA. 109. 864892.
12. Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, Baumgartner H, Finkelstein A, Legrand V, Suárez de Lezo J, Kefer J, Messika-Zeitoun D, Richardt G, Stabile E, Kaleschke G, Vahanian A, Laborde JC, Leon MB, Webb JG, Panoulas VF, Maisano F, Alfieri O, Colombo A. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv. 2015;8:e001779. Doi: 10. 1161/ CIRCINTERVENTIONS. 114. 001779.
13. Leetmaa T, Hansson NC, Leipsic J, Jensen K, Poulsen SH, Andersen HR, Jensen JM, Webb J, Blanke P, Tang M, Nørgaard BL. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv. 2015;8:e001596. Doi: 10. 1161/CIRCINTERVENTIONS. 114. 001596
14. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521-e643. Doi: 10. 1161/ CIR. 0000000000000031.
15. Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM, Haeusler KG, Boriani G, Capodanno D, Gilard M, Zeymer U, Lane D, Storey RF, Bueno H, Collet JP, Fauchier L, Halvorsen S, Lettino M, Morais J, Mueller C, Potpara TS, Rasmussen LH, Rubboli A, Tamargo J, Valgimigli M, Zamorano JL; Document Reviewers. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J. 2014;35:3155-3179. Doi: 10. 1093/eurheartj/ehu298.
16. Nijenhuis VJ, Stella PR, Baan J, Brueren BR, de Jaegere PP, den Heijer P, Hofma SH, Kievit P, Slagboom T, van den Heuvel AF, van der Kley F, van Garsse L, van Houwelingen KG, Van't Hof AW, Ten Berg JM. Antithrombotic therapy in patients undergoing TAVI: an overview of Dutch hospitals. Neth Heart J. 2014;22:64-69. Doi: 10. 1007/s12471-013-0496-6.
17. Aryal MR, Karmacharya P, Pandit A, Hakim F, Pathak R, Mainali NR, Ukaigwe A, Mahmood M, Badal M, Fortuin FD. Dual versus single antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis. Heart Lung Circ. 2015;24:185-192. Doi: 10. 1016/j. hlc. 2014. 07. 058.
18. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL; ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-2413. Doi: 10. 1093/ eurheartj/ehp285.
19. López J, Revilla A, Vilacosta I, Villacorta E, González-Juanatey C, Gómez I, Rollán MJ, San Román JA. Definition, clinical profile, microbiologicalspectrum, and prognostic factors of early-onset prosthetic valve endocarditis. Eur Heart J. 2007;28:760-765. Doi: 10. 1093/eurheartj/ehl486.
20. Tornos P, Almirante B, Olona M, Permanyer G, González T, Carballo J, Pahissa A, Soler-Soler J. Clinical outcome and long-term prognosis of late prosthetic valve endocarditis: a 20-year experience. Clin Infect Dis. 1997;24:381-386.
21. McElhinney DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the Melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv. 2013;6:292-300. Doi: 10. 1161/CIRCINTERVENTIONS. 112. 000087.
22. Généreux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, Smith C, Serruys PW, Kappetein AP, Leon MB. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3, 519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317-2326. Doi: 10. 1016/j. jacc. 2012. 02. 022.
23. Puls M, Eiffert H, Hünlich M, Schöndube F, Hasenfuß G, Seipelt R, Schillinger W. Prosthetic valve endocarditis after transcatheter aortic valve implantation: the incidence in a single-centre cohort and reflections on clinical, echocardiographic and prognostic features. EuroIntervention. 2013;8:1407-1418. Doi: 10. 4244/EIJV8I12A214.
24. Olsen NT, De Backer O, Thyregod HGH, Vejlstrup N, Bundgaard H, Søndergaard L, Ihlemann N. Prosthetic valve endocarditis after transcatheter aortic valve implantation. Circ Cardiovasc Interv. 2015;8:e001939. Doi: 10. 1161/CIRCINTERVENTIONS. 114. 001939.